-
R&D Requirements and Quality Control Strategies for Exporting APIs Overseas
China's API industry will continue to move towards a new stage of high-quality development, while enhancing domestic endogenous power and reliability ...
2023-12-08 17:09 -
Global Trade Analysis and Outlook of China's Pharmaceutical Industry in the First Half of 2023
In the first half of 2023, China's pharmaceutical industry entered a difficult stage. The overall performance of the pharmaceutical industry was poor ...
2023-12-07 16:17 -
Evelo's Rise and Fall: A Tragic Journey in Microbiome-based Therapies
Evelo, a pioneering company in the field of microbiome-based therapies, emerged as a global leader in researching immunotherapies for cancer, autoimmu...
2023-11-27 19:03 -
Pfizer's Strategic Shift in China's Pneumococcal Vaccine Market
In recent news, it has been reported that Pfizer, a leading pharmaceutical company, is dissolving its 400-member team responsible for the 13-valent pn...
2023-11-27 18:57 -
Challenges and Volatility in the Acrylic Emulsion Market in 2023
The acrylic emulsion market in 2023 has experienced significant volatility and challenges due to fluctuations in raw material prices and weak demand.
2023-11-24 15:48 -
Challenges in the Petrochemical Industry: Plummeting Oil Prices and Volatile Polymer Market
The global petrochemical industry is currently facing a confluence of challenges, including the recent decline in oil prices and the volatile nature o...
2023-11-24 15:43 -
Nippon Paint Holdings' Financial Performance and Market Strategies in China: Insights from Q3 Briefi...
On November 22, Nippon Paint Holdings (referred to as "Nippon Paint") released a summary of its Q3 financial briefing for the December 2023 period. ...
2023-11-24 14:32 -
Pharmaceutical Industry Crackdown: Chinese Authorities Target Misconduct and Strengthen Regulatory M...
In recent developments within the pharmaceutical industry, Chinese authorities have taken decisive actions to address misconduct and enhance regulator...
2023-11-24 11:57 -
Pharmaceutical Companies Terminate Multiple Pipeline Projects, Impacting Drug Development Strategies
In recent news, it has been reported that approximately 50 pipeline projects have been terminated by various pharmaceutical companies.
2023-11-24 11:52 -
Simcere Pharmaceutical Group Enters Exclusive License and Collaboration Agreement for Innovative Dru...
On November 21st, Simcere Pharmaceutical Group announced a significant milestone in its strategic expansion in the field of autoimmune diseases.
2023-11-22 18:40
Hot News
- SABIC Shuts Down 865,000-Ton U... Jul 02, 2025
- ExxonMobil Launches $10 Billio... Jul 17, 2025
- The Truth Behind the US-China ... Jun 30, 2025
- Sally Beauty Acquires Flair Ha... Jul 07, 2025
- UBE Corporation Accelerates Ch... Jul 02, 2025
Related Products